JP2024150751A5 - - Google Patents

Download PDF

Info

Publication number
JP2024150751A5
JP2024150751A5 JP2024127900A JP2024127900A JP2024150751A5 JP 2024150751 A5 JP2024150751 A5 JP 2024150751A5 JP 2024127900 A JP2024127900 A JP 2024127900A JP 2024127900 A JP2024127900 A JP 2024127900A JP 2024150751 A5 JP2024150751 A5 JP 2024150751A5
Authority
JP
Japan
Prior art keywords
antibody
seq
sequence
tslp
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024127900A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024150751A (ja
Filing date
Publication date
Priority claimed from JP2019555854A external-priority patent/JP7330896B2/ja
Application filed filed Critical
Publication of JP2024150751A publication Critical patent/JP2024150751A/ja
Publication of JP2024150751A5 publication Critical patent/JP2024150751A5/ja
Priority to JP2025147176A priority Critical patent/JP2025170430A/ja
Pending legal-status Critical Current

Links

JP2024127900A 2017-04-12 2024-08-02 抗tslp抗体による喘息治療 Pending JP2024150751A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025147176A JP2025170430A (ja) 2017-04-12 2025-09-04 抗tslp抗体による喘息治療

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201762484864P 2017-04-12 2017-04-12
US62/484,864 2017-04-12
US201762553575P 2017-09-01 2017-09-01
US201762553477P 2017-09-01 2017-09-01
US62/553,477 2017-09-01
US62/553,575 2017-09-01
JP2019555854A JP7330896B2 (ja) 2017-04-12 2018-04-12 抗tslp抗体による喘息治療
JP2023080295A JP2023099233A (ja) 2017-04-12 2023-05-15 抗tslp抗体による喘息治療

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023080295A Division JP2023099233A (ja) 2017-04-12 2023-05-15 抗tslp抗体による喘息治療

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025147176A Division JP2025170430A (ja) 2017-04-12 2025-09-04 抗tslp抗体による喘息治療

Publications (2)

Publication Number Publication Date
JP2024150751A JP2024150751A (ja) 2024-10-23
JP2024150751A5 true JP2024150751A5 (cg-RX-API-DMAC7.html) 2025-04-28

Family

ID=62092313

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019555854A Active JP7330896B2 (ja) 2017-04-12 2018-04-12 抗tslp抗体による喘息治療
JP2023080295A Withdrawn JP2023099233A (ja) 2017-04-12 2023-05-15 抗tslp抗体による喘息治療
JP2024127900A Pending JP2024150751A (ja) 2017-04-12 2024-08-02 抗tslp抗体による喘息治療
JP2025147176A Pending JP2025170430A (ja) 2017-04-12 2025-09-04 抗tslp抗体による喘息治療

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2019555854A Active JP7330896B2 (ja) 2017-04-12 2018-04-12 抗tslp抗体による喘息治療
JP2023080295A Withdrawn JP2023099233A (ja) 2017-04-12 2023-05-15 抗tslp抗体による喘息治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025147176A Pending JP2025170430A (ja) 2017-04-12 2025-09-04 抗tslp抗体による喘息治療

Country Status (21)

Country Link
US (3) US10828365B2 (cg-RX-API-DMAC7.html)
EP (1) EP3609917A1 (cg-RX-API-DMAC7.html)
JP (4) JP7330896B2 (cg-RX-API-DMAC7.html)
KR (2) KR102666879B1 (cg-RX-API-DMAC7.html)
CN (1) CN110573525A (cg-RX-API-DMAC7.html)
AU (2) AU2018253118B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019021482A2 (cg-RX-API-DMAC7.html)
CA (1) CA3059364A1 (cg-RX-API-DMAC7.html)
CL (1) CL2019002897A1 (cg-RX-API-DMAC7.html)
CO (1) CO2019011462A2 (cg-RX-API-DMAC7.html)
IL (1) IL269791B (cg-RX-API-DMAC7.html)
JO (1) JOP20190243A1 (cg-RX-API-DMAC7.html)
MX (1) MX2019012158A (cg-RX-API-DMAC7.html)
MY (1) MY207509A (cg-RX-API-DMAC7.html)
PE (1) PE20200484A1 (cg-RX-API-DMAC7.html)
PH (1) PH12019502331A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201909322VA (cg-RX-API-DMAC7.html)
TN (1) TN2019000289A1 (cg-RX-API-DMAC7.html)
TW (2) TWI856945B (cg-RX-API-DMAC7.html)
UY (1) UY37676A (cg-RX-API-DMAC7.html)
WO (1) WO2018191479A1 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180042433A (ko) * 2015-09-09 2018-04-25 노파르티스 아게 흉선 기질 림포포이에틴 (tslp)-결합 항체 및 항체의 사용 방법
JOP20190243A1 (ar) * 2017-04-12 2019-10-13 Medimmune Llc علاج الربو بجسم مضاد لـ tslp
CN116751295A (zh) 2019-06-04 2023-09-15 江苏恒瑞医药股份有限公司 能结合胸腺基质淋巴细胞生成素的抗体及其应用
CA3147044A1 (en) * 2019-07-11 2021-01-14 Tavotek Biotherapeutics (Hong Kong) Limited Agents that interfere with thymic stromal lymphopoietin (tslp)-receptor signaling
US12479912B2 (en) 2019-09-04 2025-11-25 Biosion Inc. Monoclonal antibodies which bind thymic stromal lymphopoietin (TSLP), encoding polynucleotides thereof and methods of use thereof to treat diseases
IL292437A (en) * 2019-10-28 2022-06-01 Medimmune Ltd Dry powder formulations of antibodies that bind thymic lymphopoietin (tslp) and methods of using them
CN114887053A (zh) * 2019-11-29 2022-08-12 康诺亚生物医药科技(成都)有限公司 一种tslp相关病症治疗剂的开发和应用
US20220363781A1 (en) * 2019-12-13 2022-11-17 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Anti-tslp antibody and uses thereof
TW202140550A (zh) 2020-01-29 2021-11-01 瑞士商諾華公司 使用抗tslp抗體治療炎性或阻塞性氣道疾病之方法
EP4103605A1 (en) * 2020-02-13 2022-12-21 Amgen Inc. Treatment of atopic dermatitis with anti-tslp antibody
AU2021219839A1 (en) * 2020-02-13 2022-08-25 Amgen Inc. Formulations of human anti-TSLP antibodies and methods of treating inflammatory disease
JP2023513833A (ja) * 2020-02-18 2023-04-03 アムジェン インコーポレイテッド ヒト抗tslp抗体の製剤及びそれを使用する方法
CN113388035A (zh) * 2020-03-13 2021-09-14 迈威(上海)生物科技股份有限公司 特异性针对人tslp的抗体及其应用
WO2022117079A1 (zh) * 2020-12-03 2022-06-09 江苏恒瑞医药股份有限公司 结合胸腺基质淋巴细胞生成素的抗体及其应用
CN113501878B (zh) * 2021-02-03 2022-12-02 北京智仁美博生物科技有限公司 针对人tslp的多种抗体及其用途
CN114853888B (zh) * 2021-02-05 2023-11-03 上海洛启生物医药技术有限公司 抗tslp纳米抗体及其应用
MX2023009971A (es) * 2021-03-03 2023-09-05 Chia Tai Tianqing Pharmaceutical Group Co Ltd Composicion farmaceutica que contiene anticuerpo anti-tslp.
KR20230172508A (ko) * 2021-04-19 2023-12-22 메디뮨 리미티드 안정성이 개선된 항-tslp fab
IL307439A (en) 2021-04-23 2023-12-01 Amgen Inc Different anti-TSLP antibodies
BR112023021867A2 (pt) 2021-04-23 2023-12-19 Amgen Inc Composições de anticorpo anti-tslp e seus usos
CN113683694B (zh) 2021-09-03 2022-05-13 江苏荃信生物医药股份有限公司 一种抗人tslp单克隆抗体及其应用
CN116217724B (zh) * 2021-12-02 2023-10-27 北京东方百泰生物科技股份有限公司 一种抗tslp的单克隆抗体、其抗原结合片段及其应用
CN117327176A (zh) * 2022-06-24 2024-01-02 南京融捷康生物科技有限公司 一种抗tslp的单域抗体及其用途
US12110324B2 (en) 2022-07-22 2024-10-08 Flagship Pioneering Innovations Vi, Llc Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP)
UY40500A (es) 2022-10-26 2024-04-30 Amgen Inc Composiciones de anticuerpos anti-tslp y usos de las mismas
AR133648A1 (es) * 2023-08-25 2025-10-22 Proteologix Us Inc Constructos de anticuerpos anti-tslp y sus usos
TW202525846A (zh) 2023-08-25 2025-07-01 美商普羅特歐拉吉克適美國公司 抗il—13多特異性抗體構築體及其用途
CN117551195B (zh) * 2024-01-12 2024-04-09 杭州畅溪制药有限公司 靶向tslp的vhh纳米抗体及其应用
WO2025179220A1 (en) * 2024-02-22 2025-08-28 Flagship Pioneering Innovations Vi, Llc Dosing of antigen binding molecules targeting thymic stromal lymphopoietin (tslp)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
DE69133566T2 (de) 1990-01-12 2007-12-06 Amgen Fremont Inc. Bildung von xenogenen Antikörpern
WO1992003918A1 (en) 1990-08-29 1992-03-19 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
NZ255101A (en) 1992-07-24 1997-08-22 Cell Genesys Inc A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
ATE390933T1 (de) 1995-04-27 2008-04-15 Amgen Fremont Inc Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8
US7982016B2 (en) * 2007-09-10 2011-07-19 Amgen Inc. Antigen binding proteins capable of binding thymic stromal lymphopoietin
US8359965B2 (en) 2007-09-17 2013-01-29 Oxford J Craig Apparatus and method for broad spectrum radiation attenuation
TW201018482A (en) 2008-08-08 2010-05-16 Glaxo Wellcome Mfg Pte Ltd Novel treatment
EP3594356A1 (en) 2009-11-04 2020-01-15 Merck Sharp & Dohme Corp. Engineered anti-tslp antibody
WO2012007495A1 (en) 2010-07-15 2012-01-19 F. Hoffmann-La Roche Ag Antibodies specifically binding to human tslpr and methods of use
US9100245B1 (en) 2012-02-08 2015-08-04 Amazon Technologies, Inc. Identifying protected media files
US9306926B2 (en) 2013-03-15 2016-04-05 Brian A. Truong User authentication using unique hidden identifiers
CA2924873A1 (en) * 2013-10-23 2015-04-30 Genentech, Inc. Methods of diagnosing and treating eosinophilic disorders
SG10201913611QA (en) * 2014-08-08 2020-03-30 Alector Llc Anti-trem2 antibodies and methods of use thereof
UY36578A (es) 2015-03-11 2016-09-30 Glaxosmithkline Ip Dev Ltd Proteínas de unión a tslp
UY36889A (es) * 2015-09-09 2017-04-28 Novartis Ag Moléculas de unión a linfopoyetina estromal timica (tslp) y métodos de uso de las moléculas
JOP20190243A1 (ar) * 2017-04-12 2019-10-13 Medimmune Llc علاج الربو بجسم مضاد لـ tslp

Similar Documents

Publication Publication Date Title
JP2024150751A5 (cg-RX-API-DMAC7.html)
JP7766392B2 (ja) 治療用抗cd40リガンド抗体
JP2022105178A (ja) 黄色ブドウ球菌(staphylococcus aureus)感染症を治療および予防するための組成物および方法
JP2018183173A5 (cg-RX-API-DMAC7.html)
JP6513657B2 (ja) Il−17a結合剤およびその用途
JP2020509756A5 (cg-RX-API-DMAC7.html)
JP2008502366A5 (cg-RX-API-DMAC7.html)
JP2013056885A5 (cg-RX-API-DMAC7.html)
JP2018519364A5 (cg-RX-API-DMAC7.html)
JP2019527194A5 (cg-RX-API-DMAC7.html)
ME02371B (me) Sastojci i postupci za dijagnstikovanje i tretman raka
US20240209082A1 (en) Anti-cd96 antibodies and methods of use thereof
RU2019140602A (ru) АНТИ-GARP-TGF-β-АНТИТЕЛА
JP2010536378A5 (cg-RX-API-DMAC7.html)
JPWO2019147831A5 (cg-RX-API-DMAC7.html)
JPWO2018191479A5 (cg-RX-API-DMAC7.html)
JP2018522540A5 (cg-RX-API-DMAC7.html)
JP2018529635A5 (cg-RX-API-DMAC7.html)
JP2020527152A5 (cg-RX-API-DMAC7.html)
JP2013508292A5 (cg-RX-API-DMAC7.html)
JP2020502233A5 (cg-RX-API-DMAC7.html)
RU2019140933A (ru) Средства, пути применения и способы лечения
JP2018529661A5 (cg-RX-API-DMAC7.html)
JP2020504135A5 (cg-RX-API-DMAC7.html)
JPWO2020180819A5 (cg-RX-API-DMAC7.html)